Annual report on transcatheter left atrial appendage closure in 2024
- VernacularTitle:2024年经导管左心耳封堵术年度报告
- Author:
Yuan BAI
1
;
Xiaochun ZHANG
2
;
Jie ZENG
3
;
Yongjian WU
4
;
Daxin ZHOU
2
Author Information
1. Department of Cardiology, Changhai Hospital, Navy Military Medical University, Shanghai, 200433, P. R. China
2. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China
3. Department of Cardiology, Sichuan Provincial People's Hospital, Chengdu, 610072, P. R. China
4. Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, 100037, P. R. China
- Collective Name:Representatives of Structural Cardiology Committee of Cardiovascular Physicians Branch of Chinese Medical Doctor Association, National Clinical Research Center for Interventional Medicine, China Heart House
- Publication Type:Journal Article
- Keywords:
Transcatheter left atrial appendage closure;
interventional therapy;
atrial fibrillation;
annual report
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2025;32(06):746-751
- CountryChina
- Language:Chinese
-
Abstract:
After two decades of development, transcatheter left atrial appendage closure has emerged as a safe and effective intervention for stroke prevention in patients with atrial fibrillation. In 2024, significant advancements were made in the field of left atrial appendage closure in terms of evidence-based medicine, device research and development, and guideline consensus. The annual report on transcatheter left atrial appendage closure systematically reviews global academic progress in 2024, encompassing newly published clinical evidence, recently developed occlusion devices, and updated international guidelines/consensus statements. In the future, the development direction of transcatheter left atrial appendage closure mainly includes expanding surgical indications, optimizing imaging assistance technology, improving closure device design, and exploring individualized strategies for postoperative antithrombotic therapy.
